NASDAQ Equity Snapshot

BLTE Weekly Equity Report

Belite Bio Inc ADR

Interactive chart JSON snapshot
Latest Close 138.2 USD 12 Jun 2026
1W Return -3.6% latest completed week
4W Return -3.4% short-term follow-through
12W Return -10.6% quarterly tape
Trend Breadth 84.6% 44 of 52 weeks active
Volume Ratio 0.9x vs 13-week average
Company Brief

What the company does

Belite Bio, Inc, a clinical-stage biopharmaceutical drug development company, is engaged in the research and development of novel therapies targeting age-related atrophic macular degeneration and autosomal recessive stargardt diseases. The company is headquartered in San Diego, California.

Snapshot

What the weekly tape is saying

BLTE closed the latest completed week at 138.2 USD. The 4-week return is -3.4% and the 12-week return is -10.6%. Trend Signal is inactive, Market Dynamics is -1.13. Setup signature: Risk-first tape with a 31/100 composite read.

Trend Signal Inactive
Market Dynamics No fresh buy
Price vs Trend -12.4%
Volume 0.9x
Setup Cockpit

A compressed read of the whole setup

The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.

Composite setup radar

Scoreboard

Trend 47 Persistence of active Trend Signal over the last year and current streak.
Momentum 33 Blend of 4-week and 12-week follow-through.
Dynamics 31 Latest Market Dynamics and whether pressure has improved over four weeks.
Relative Strength 25 Relative leadership and short-term RS change.
Volume 40 Participation compared with the 13-week volume baseline.
Risk Control 12 Drawdown and recent weekly volatility pressure.

16-week signal tape

27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 2 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun
Weekly return bar Trend Signal dot Positive Market Dynamics dot
Price Action

Price, Trend Line, and Fair Value

Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.

52-week price path

Price Trend Line Fair Value

Price map

Trend Line
157.7 USD
Vs Trend Line
-12.4%
Fair Value
72.69 USD
Vs Fair Value
90.1%
52W High
200.0 USD
52W Low
56.10 USD
Drawdown
-30.9%
Range Position
57.0%
Momentum

Returns and trend persistence

Return windows separate the latest week from short-term and medium-term follow-through.

Return windows

1W -3.6%
4W -3.4%
12W -10.6%
26W -2.2%
52W 132.0%

Trend read

Active Streak
0 weeks
52W Active Weeks
44
52W Active Breadth
84.6%
Sector Scope
US Healthcare
Sector Rank
776 of 1038
Sector Percentile
25.3%
Peer Context

Sector and industry pulse

Peer breadth helps separate a stock-specific move from a broader group rotation.

Market Dynamics

Pressure, Relative Strength, and expectation

Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.

Dynamics path

Market Dynamics Relative Strength

Signal state

Market Dynamics
-1.13
4W MD Change
14.4%
Relative Strength
-3.62
4W RS Change
-178.2%
Expectation
Positive
Probability
60.30%
Volume

Participation and confirmation

Volume tells us whether the latest weekly move is being confirmed by unusual participation.

52-week volume profile

Volume map

Latest Volume
789.0K
13W Average
838.8K
52W Average
702.9K
Vs 13W
0.9x
Vs 52W
1.1x
Risk Anatomy

Volatility, downside weeks, and return shape

A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.

26-week return distribution

Risk map

13W Volatility
4.9%
52W Volatility
5.7%
Upside Weeks
30
Downside Weeks
22
Downside Breadth
42.3%
Avg Gain / Loss
5.8% / -3.7%
Context

Classification, opportunities, risks, and watch points

Top-level read across company classification, constructive evidence, caution points, and the next things that matter.

Classification

Exchange
NASDAQ
Country
US
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Market Cap
5.9B

Opportunity signals

  • Price is above Fair Value, showing premium demand versus the model.

Risk signals

  • Trend Signal is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Market Dynamics is negative, which weakens the current setup.
  • The share remains more than 20% below its 52-week high.

Watch next

  • Trend Line remains the key weekly regime level.
  • Market Dynamics is the pressure gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Weekly Tape

Recent completed weeks

The latest weekly rows behind the report snapshot.

Week Close Return Trend Fair Value MD RS Volume Signal
12 Jun 2026 138.2 USD -3.6% 157.7 USD 72.69 USD -1.13 -3.62 789.0K Off
5 Jun 2026 143.3 USD -0.6% 157.0 USD 71.89 USD -1.12 3.09 1.6M Off
29 May 2026 144.2 USD 5.0% 155.9 USD 71.06 USD -1.22 -0.11 1.4M Off
22 May 2026 137.3 USD -4.0% 154.7 USD 70.25 USD -1.33 -1.45 804.8K Off
15 May 2026 143.0 USD -7.7% 153.2 USD 69.52 USD -1.32 4.63 730.1K Off
8 May 2026 154.9 USD 0.0% 151.3 USD 68.75 USD -1.20 13.84 556.2K On
1 May 2026 154.8 USD -4.0% 148.8 USD 67.92 USD -1.04 21.19 362.5K On
24 Apr 2026 161.3 USD -2.5% 146.2 USD 67.11 USD -0.90 29.49 414.5K On
17 Apr 2026 165.4 USD -4.2% 143.1 USD 66.26 USD -0.88 37.61 924.0K On
10 Apr 2026 172.8 USD 1.7% 140.0 USD 65.39 USD -0.92 54.62 832.2K On
2 Apr 2026 169.8 USD 11.7% 136.5 USD 64.47 USD -0.93 61.47 755.1K On
27 Mar 2026 152.1 USD -1.6% 133.1 USD 63.56 USD -0.75 52.86 847.2K On
20 Mar 2026 154.6 USD -5.8% 130.1 USD 62.78 USD -0.31 52.49 881.1K On
13 Mar 2026 164.1 USD -5.3% 127.1 USD 61.96 USD 0.04 60.92 656.3K On